chr2-112779589-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_000575.5(IL1A):c.397G>A(p.Glu133Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000372 in 1,612,504 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000575.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IL1A | NM_000575.5 | c.397G>A | p.Glu133Lys | missense_variant | 5/7 | ENST00000263339.4 | NP_000566.3 | |
IL1A | NM_001371554.1 | c.397G>A | p.Glu133Lys | missense_variant | 5/7 | NP_001358483.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IL1A | ENST00000263339.4 | c.397G>A | p.Glu133Lys | missense_variant | 5/7 | 1 | NM_000575.5 | ENSP00000263339 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000132 AC: 20AN: 152068Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000875 AC: 22AN: 251354Hom.: 0 AF XY: 0.000110 AC XY: 15AN XY: 135838
GnomAD4 exome AF: 0.0000274 AC: 40AN: 1460436Hom.: 0 Cov.: 30 AF XY: 0.0000344 AC XY: 25AN XY: 726556
GnomAD4 genome AF: 0.000132 AC: 20AN: 152068Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74252
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 29, 2023 | The c.397G>A (p.E133K) alteration is located in exon 5 (coding exon 4) of the IL1A gene. This alteration results from a G to A substitution at nucleotide position 397, causing the glutamic acid (E) at amino acid position 133 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at